Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study

Yang, JL; Dong, LH; Yang, S; Han, XH; Han, Y; Jiang, SY; Yao, JR; Zhang, ZS; Zhang, SX; Liu, P; Qin, Y; Wu, H; Feng, H; Yao, S; Sun, Y; Song, HF; Shi, YK

Shi, YK (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.

EUROPEAN JOURNAL OF CANCER, 2020; 130 (): 182

Abstract

Purpose: This is a first-in-human phase I study investigating the safety and efficacy of toripalimab, a humanized monoclonal antibody against the prog......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索